Marco Craveiro

Marco Craveiro is an accomplished scientist with extensive experience in immunology and molecular biology. Currently serving as an Associate Research Scientist at RemedyBiz, Inc. since March 2022, Marco's role involves research at the National Institute of Deafness and Communication Disorders. Since November 2014, Marco has held a position as a Scientist at the National Institutes of Health, contributing to Dr. Alfred Singer's lab in understanding T cell repertoire selection and the homeostasis of CD4 T cells. Marco has also lectured on T cell development for the Annual Experimental Immunology Branch Immunology Course and previously worked as a Scientist at Astrix Technology Group. Early career experiences include postdoctoral research at the Institute of Molecular Genetics of Montpellier and a PhD in Neuroscience and Cell Biology from the Center for Neuroscience and Cell Biology, Coimbra, Portugal, complemented by a Bachelor's degree in Biochemistry from Universidade de Coimbra.